Top compounds associated with response to LYPLA2


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.01
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.12 0.01
mRNA KU-0063794 CTRPv2 pan-cancer AAC -0.086 0.02
mRNA Crizotinib gCSI pan-cancer AAC -0.14 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA BHG712 GDSC1000 pan-cancer AAC -0.071 0.02
mRNA BMS-270394 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA tandutinib CTRPv2 pan-cancer AAC -0.085 0.02
mRNA B02 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA Rapamycin gCSI pan-cancer AAC -0.14 0.02
Download CSV